[PDF] Top 20 Mesenchymal stem cells avoid allogeneic rejection

... of allogeneic MSC from both in vitro and in vivo studies that show MSC avoid normal ...T cells and no incidence of graft v host disease when allogeneic MSC were infused into patients with ... See full document

... inhibited rejection. Immunohistochemical results for CD4+ T cells were similar, with extensive infiltration of CD4+ T cells in rejected grafts from Group A ...Inflammatory cells number (Fig. ... See full document

... Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative modality for many hematological malignancies. The number of patients undergoing this procedure is rapidly increasing ... See full document

... There were no adverse reactions to AT-MSCs follow- ing IV injection. However, we did find increased CD8 + T-cell numbers following repeated injection of BM- MSCs in healthy horses. These data suggest that re- peated ... See full document

... tion) allogeneic (n = 5) or autologous (n = 13) ASCs, 1 month apart, as previously described [22, ...[30]. Allogeneic ASCs were derived from 2 separate SPF cats. Cells for treatment were from the ... See full document

... min. Cells were added to make a final concentration of 125 μg/ mL HMPAO, 20 mCi 99m Tc for cell loading (22 ...Labeled cells were injected at a concentration of 100 million cells in 5 ...of ... See full document

... cats, cells were harvested by trypsinization at passage 3 and resuspended in 10 ml DPBS with 200 IU heparin sulfate and administered as a slow intravenous push over 20 ... See full document

... Although the use of autologous MSCs for cell therapy has been well established and accepted, the need of pro- longed time for MSC culture to obtain therapeutic dose and the narrow time window for their optimal applica- ... See full document

... amputation was treated with four sequential intravenous infusions of allogeneic BM-MSCs, a total of 3.4 x 10 8 cells, from a healthy donor. The infusion of BM-MSCs passed the safety issue and showed no ... See full document

... of cells in the microglia with an anti-inflammatory phenotype (Wirjatijasa et ...microglia/macrophage cells with an anti-inflammatory phenotype and reducing astrocyte ... See full document

... undifferentiated allogeneic MSCs were shown to engraft, provide functional improvement for up to 3 months and differentiate into vascular endo- thelium, smooth muscle and ...these cells elicit an ... See full document

... The complications encountered after intra-arterial stem cell transplantation seem to depend, to some extent at least, on the infusion technique, cell size, and infusion velocity [14,15]. Janowski et al. [15] ... See full document

... The greatest advantage of BM-MSC treatment is that BM-MSCs have no or limited immunoge- nicity. BM-MSCs can not only survive homoge- neously, but also heterogeneously, and main- tain multi-differentiation competence ... See full document

... UC-MSCs were successfully differentiated into osteo- blasts, adipocytes, and chondroblasts. In the induced medium geared toward osteoblast differentiation, UC- MSCs gradually changed their morphology to a longer shape ... See full document

... The phenotype of both Balb/c and C3H MSC was determined by flow cytometry using a panel of markers commonly used in stem cell analysis. P3 (early) and P12 (late) cultures were analysed to determine whether pro- ... See full document

... 6 cells via enema 3 h after the induction of ...Results: Cells isolated from both sources were adherent to plastic, multipotent and expressed some human MSC surface ... See full document

... marrow-derived cells [84]. These cells can differentiate in vitro into various mesen- chymal cell types, but inflammatory cytokines such as IL-1β prevent the multilineage ...and allogeneic peripheral ... See full document

... stress, avoid- ing DNA damage and chromosomal aberration could result from MSCs cultured under hypoxia condition ...be stem-like, up-express typical surface markers and main- tain multiple differentiation ... See full document

... (subamniotic) MSCs isolated using a previously estab- lished protocol in our lab [12]. Briefly, human umbilical cord samples from healthy donors were screened, dis- sected at the envelope membranes, and cultured. These ... See full document

... matched unrelated donor is not available, and haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) has become an optional choice. The proto- cols in Haplo-HSCT have dramatically improved over the ... See full document